“…Subsequently, studies investigating the anticancer activity of BCA were carried out in different cancer cell lines, followed by animal models. Many types of tumors could be inhibited by BCA, such as lung cancer (Lee et al, 1991), prostate cancer (Peterson and Barnes, 1993; Sun et al, 1998), gastrointestinal tract cancer (Yanagihara et al, 1993), pancreatic cancer (Bhardwaj et al, 2014), breast cancer (Balabhadrapathruni et al, 2000; Sehdev et al, 2009), osteosarcoma (Hsu et al, 2018; Zhao et al, 2018), malignant melanoma (Xiao et al, 2017), and tumors of the central nervous system (Sehm et al, 2014). However, the ability of BCA to inhibit the growth of some types of cancer cells was weaker than that of GEN (Peterson and Barnes, 1991), but the anticancer usage of BCA might be broader because of its targeting of anticancer activity, especially in malignant brain tumors (Sehm et al, 2014).…”